Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 1/20 | 0.54 |
| ▸ | CDK2 | P24941 | 6/20 | 0.53 |
| ▸ | MAPK14 | Q16539 | 7/20 | 0.47 |
| ▸ | MAPK11 | Q15759 | 3/20 | 0.47 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.46 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.46 |
| ▸ | LCK | P06239 | 2/20 | 0.43 |
| ▸ | KIT | P10721 | 2/20 | 0.43 |
| ▸ | KDR | P35968 | 2/20 | 0.43 |
| ▸ | HPGDS | O60760 | 1/20 | 0.43 |
| ▸ | TTK | P33981 | 4/20 | 0.42 |
| ▸ | GPR39 | O43194 | 1/20 | 0.42 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.41 |
| ▸ | RAF1 | P04049 | 1/20 | 0.41 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.41 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.41 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12953507 | 0.90 | GSK3B (0.69) | GSK3BCDK2CCNA2CCNA1 | |
| SCHEMBL13304914 | 0.89 | GSK3B (0.54) | GSK3BCDK2MAPK14MAPK11CCNA2 | |
| SCHEMBL13305403 | 0.89 | GSK3B (0.59) | GSK3BCDK2CCNA2CCNA1GPR39 | |
| SCHEMBL13305705 | 0.88 | GSK3B (0.56) | GSK3BCDK2CCNA2CCNA1GPR39 | |
| SCHEMBL12954300 | 0.87 | GSK3B (0.53) | GSK3BCDK2MAPK14MAPK11CCNA2 | |
| SCHEMBL12953764 | 0.87 | GSK3B (0.67) | GSK3BCDK2CCNA2CCNA1 | |
| SCHEMBL14050764 | 0.87 | GSK3B (0.53) | GSK3BCDK2CCNA2CCNA1 | |
| SCHEMBL12953016 | 0.87 | GSK3B (0.67) | GSK3BCDK2CCNA2CCNA1 | |
| SCHEMBL13305188 | 0.87 | GSK3B (0.63) | GSK3BCDK2CCNA2CCNA1GPR39 | |
| SCHEMBL13305399 | 0.86 | GSK3B (0.56) | GSK3BCDK2CCNA2CCNA1GPR39 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1537116-B1 | PYRAZOLOPYRIMIDINES SUITABLE FOR THE TREATMENT OF CANCER DISEASES | SCHERING CORP (US) | 2010-06-02 | — | — | EP | disclosed |